> Zydus launched its hep C drug in India under Gilead ($GILD) license. Story
> Vivo Capital raises $750 million in 8th fund focused on U.S., Greater China. Release
> Mundipharma touted Betadine formulations effectiveness in minimizing risk of human-to-human Ebola transmission. Release (PDF)
> TaiGen signs agreement with Cellex and the University Hospital Carl Gustav Carus Dresden in Germany in an investigator-initiated stem cell clinical trial. Release
> Australia's Mesoblast wins Japan External Trade Organization fast-track status on stem-cell investments. Release